AKV-9

N/A

Report date: 2023/08/28 18:00:59
NME

Base Information

Drug NameAKV-9
Drug Alias NameAKV9AKV-9NU-9
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein aggregation inhibitors
TargetsNot applicable
Therapy Area/IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesNorthwestern University
China Registration ClassN/A

Develop Information

Active CompaniesAkava Therapeutics IncAkava Therapeutics LLCNorthwestern University
Inactive CompaniesN/A
Active IndicationsMotor Neuron DiseaseAmyotrophic Lateral SclerosisAlzheimer Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A